PREVENTION OF DIABETIC NEPHROPATHY WITH ENALAPRIL IN NORMOTENSIVE DIABETICS WITH MICROALBUMINURIA

被引：437

作者：

MARRE, M

CHATELLIER, G

LEBLANC, H

GUYENE, TT

MENARD, J

PASSA, P

机构：

[1] HOP PITIE SALPETRIERE, SERV INFORMAT, F-75013 PARIS, FRANCE

[2] HOP ST LOUIS, SERV DIABET, F-75475 PARIS 10, FRANCE

[3] INSERM, U36, F-75005 PARIS, FRANCE

来源：

BMJ-BRITISH MEDICAL JOURNAL | 1988年 / 297卷 / 6656期

关键词：

D O I：

10.1136/bmj.297.6656.1092

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1092 / 1095

页数：4

共 37 条

[1] ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[2] THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT
ANDERSON, S
RENNKE, HG
BRENNER, BM
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) : 1993 - 2000
[3] EVIDENCE AGAINST INCREASED GLOMERULAR PRESSURE INITIATING DIABETIC NEPHROPATHY
BANK, N
KLOSE, R
AYNEDJIAN, HS
NGUYEN, D
SABLAY, LB
[J]. KIDNEY INTERNATIONAL, 1987, 31 (04) : 898 - 905
[4] CHRISTENSEN CK, 1985, HYPERTENSION, V7, P109
[5] CHRISTENSEN CK, 1984, DIABETIC NEPHROPATHY, V3, P92
[6] DCCT Res Grp, 1986, DIABETES, V35, P530
[7] DIXON WJ, 1983, BIOMEDICAL PROGRAMS
[8] ELVING LD, 1987, DIABETOLOGIA, V30, pA517
[9] Feldt-Rasmussen B, 1984, DIABETIC NEPHROPATHY, V3, P101
[10] FELDTRASMUSSEN B, 1986, LANCET, V2, P1300